A comprehensive review found the endocannabinoid system is involved in movement control, memory, and appetite, and may contribute to the pathology and offer therapeutic targets for Huntington's, Parkinson's, schizophrenia, and tremor.
Read this if you want to understand how the endocannabinoid system relates to major neurological diseases.
CB1 receptor loss in Huntington's occurs early and may contribute to involuntary movements
What the researchers found
This review synthesized the rapidly growing understanding of the endocannabinoid system's role in neurological disease.
The endocannabinoid system, consisting of two receptors (CB1, CB2) and two endogenous ligands (anandamide, 2-AG), is involved in normal movement control, memory formation, and appetite regulation. As this physiological role became clearer, evidence emerged that the system may be disrupted in several neurological diseases.
For Huntington's disease, loss of CB1 receptors in the basal ganglia occurs early and may contribute to the characteristic involuntary movements. For Parkinson's disease, endocannabinoid levels appear altered, and cannabinoids may help treat levodopa-induced dyskinesia. For schizophrenia, the interaction between cannabinoid and dopamine systems may contribute to psychotic symptoms. For tremor, cannabinoids showed direct therapeutic potential.
The review identified an array of potential therapeutic approaches: cannabinoid agonists, antagonists, and compounds that modify endocannabinoid synthesis, uptake, or metabolism.
Why it matters
This review reframed neurodegenerative diseases through the lens of the endocannabinoid system, suggesting that cannabis-based medicines might not just treat symptoms but address underlying pathophysiology in some conditions.
The numbers in context
Two receptors (CB1, CB2). Two endogenous ligands (anandamide, 2-AG). Four diseases reviewed: Huntington's, Parkinson's, schizophrenia, tremor.
How the study worked
Comprehensive narrative review of endocannabinoid system involvement in four neurological conditions, covering receptor distribution, endocannabinoid levels, and potential therapeutic targets.
What this study cannot tell us
Much of the evidence was preclinical at the time of publication. The therapeutic applications proposed were largely theoretical. The complexity of the endocannabinoid system means that simple agonist or antagonist approaches may have unintended effects.
How to read the evidence
A comprehensive narrative review synthesizing preclinical and early clinical evidence. Provides a strong conceptual framework but many proposed applications were speculative.
When this study was published
Published in 2001. Research on endocannabinoid involvement in neurodegenerative diseases has expanded substantially.
The bigger picture
The concept of endocannabinoid system dysfunction in neurological disease has expanded substantially since this review. Research into CB1 receptor loss in Huntington's and endocannabinoid modulation in Parkinson's continues to be active.
Questions still open
- Have cannabinoid-based treatments been developed for any of these conditions? Is CB1 receptor loss a cause or consequence of Huntington's pathology? Could endocannabinoid-boosting drugs be safer than direct agonists?
Common questions
Is the endocannabinoid system involved in neurological diseases?
Could cannabis treat these diseases?
Read the original research
The role of cannabinoids in neurodegenerative diseases.
Progress in neuro-psychopharmacology & biological psychiatry, 25(4), 743-65
Citation
Glass, M. (2001). The role of cannabinoids in neurodegenerative diseases.. Progress in neuro-psychopharmacology & biological psychiatry, 25(4), 743-65.
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)